A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib Plus Trastuzumab Without Chemotherapy in HER2+ Breast Cancer.
Jamunarani Veeraraghavan,Carolina Gutierrez,Carmine De Angelis,Robert Davis,Tao Wang,Tomas Pascual,Pier Selenica,Katherine Sanchez,Hiroaki Nitta,Monesh Kapadia,Anne C. Pavlick,Patricia Galvan,Brent Rexer,Andres Forero-Torres,Rita Nanda,Anna M. Storniolo,Ian E. Krop,Matthew P. Goetz,Julie R. Nangia,Antonio C. Wolff,Britta Weigelt,Jorge S. Reis-Filho,Susan G. Hilsenbeck,Aleix Prat,C. Kent Osborne,Rachel Schiff,Mothaffar F. Rimawi CLINICAL CANCER RESEARCH（2023）
关键词
Breast Cancer,HER2,Metastatic Breast Cancer
AI 理解论文
溯源树
样例
